The evidence is mixed2 supporting, 3 against, 0 worth knowing
Supporting
revenue grew 20% year on year in the quarter ending 30 June 2026
net margin has widened from -9.9% to 1.1% across four quarters
Against
trading 3% below its 200-day average
down 5% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
nothing the data supports either way
What would change this read: a close back above 401, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working1
Revenue rose 19.7% year on year, from Rs 167 cr to Rs 200 cr.
+19.7%Rs 167 crRs 200 cr
Needs watching7
Net profit -44.4% year on year, Rs 4 cr to Rs 2 cr.
-44.4%Rs 4 crRs 2 cr
Profit grew slower than revenue, -44.4% against +19.7%.
-44.4%+19.7%
Net margin fell from 2.4% to 1.1%.
2.4%1.1%
Trading 3.1% below its 200-day average.
-3.1%
36% below its 52-week high.
-36%
A warning rule fires on it tonight: lost the 200-day line.
Lost the 200-day line
Only Rs 3.9 crore changes hands on a median day. A large order moves this price by itself.
Rs 3.9 cr
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
1 of 47 matched on 10 Sep
PANACEABIO matches 1 of the 47 scans today, across 1 different kinds of evidence.
PANACEABIO trades at 214× trailing earnings, close to its median of 232× over this window. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
AGM / EGM filings were typically +0.17pt vs the market over the next 5 sessions (n=8,423) · Results filings were typically -0.51pt vs the market over the next 5 sessions (n=7,726) · Board meeting filings were typically +0.02pt vs the market over the next 5 sessions (n=6,172)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 20% against the same quarter a year earlier
net margin widened from -0.6% to 1.1%
revenue rose in 3 of the last 4 quarters
Going against it
profit dropped 44% year on year
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
200
4
2
0.38
1.1%
Q4 FY26
31 Mar · consolidated
167
-1
-1
0.08
-0.6%
Q3 FY26
31 Dec · consolidated
165
6
4
0.65
2.4%
Q2 FY26
30 Sep · consolidated
141
-19
-14
—
-9.9%
Q1 FY26
30 Jun · consolidated
167
7
4
0.66
2.4%
Q4 FY25
31 Mar · consolidated
133
-0
-2
—
-1.5%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-12.2%
Versus 200-day average-3.1%
Below 52-week high-36.1%
Above 52-week low+31.3%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)35.7
Higher closes in last 52 of 5
Six-month return+13.99%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.